TP53 and neoplasm: Emerging research has elucidated the potential impact of IKBKB activity on tumor development, highlighting its ability to exert negative regulatory effects on key proteins involved in cell cycle regulation and tumor suppression, including members of the p53 family, p16, and TSC1 [28].